The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effects of angiotensin-converting enzyme (ACE) inhibitors on the outcomes of patients receiving primary radiotherapy for prostate cancer (PC).
Weranja Kalana Bodhisiri Ranasinghe
No relevant relationships to disclose
Scott G. Williams
No relevant relationships to disclose
Shomik Sengupta
No relevant relationships to disclose
Mike Chang
No relevant relationships to disclose
Arthur Shulkes
No relevant relationships to disclose
Damien M. Bolton
No relevant relationships to disclose
Graham Baldwin
No relevant relationships to disclose
Oneel Patel
No relevant relationships to disclose